#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital nephrogenic diabetes insipidus Langerhans' cell histiocytosis Arterial tortuosity syndrome Ventricular fibrillation Uveal melanoma Carcinoid tumour Follicular lymphoma stage I Pulmonary alveolar haemorrhage Congenital generalised lipodystrophy Pancreatic neuroendocrine tumour Hepatic angiosarcoma Superficial vein thrombosis Hereditary angioedema Cholangiocarcinoma Immune thrombocytopenia More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Treatment Carcinoid syndrome – Diagnostics Marginal zone lymphoma refractory Atypical teratoid/rhabdoid tumour of CNS – Treatment Loeys-Dietz syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Basic Information Rhabdomyosarcoma – Trials in Disease Myelodysplastic syndrome – Life with Disease Glomerulonephritis membranous – Life with Disease Chordoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000014593 Abc-15Bo-116 A52 Elenestinib Phosphate AMG 732 Sulfamethizole Isaralgagene Civaparvovec UDONITRECTAG Ceftriaxone Sodium Estriol Dried Ferrous Sulfate H2-Receptor Antagonists Metoclopramide Anakinra Nemvaleukin Alfa Cat Epithelia Atomoxetine Nintedanib Bicalutamide Patiromer More therapies…

    Learn about Your Condition

    Staphylococcal bacteraemia Tardive dyskinesia Solitary fibrous tumour Subdural haematoma Renal failure Osteogenesis imperfecta Embolism venous Oropharyngeal cancer recurrent Brain neoplasm malignant Mitral valve incompetence Asthmatic crisis Carpal tunnel syndrome Keratosis follicular Ligament operation Diabetic retinopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

    Recruiting

    3 1
    Investigated Drugs:
    • LY3841136 SODIUM
    Czechia Germany Poland Slovakia Spain

  • Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    Belgium Bulgaria Denmark France Greece The Netherlands +3

  • Resistance Training to Preserve Thigh Muscle Volume in Adults with Obesity Treated with Tirzepatide (Phase IV Randomized Trial)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tirzepatide
    Germany

  • Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Azd5004
    Germany Italy Poland Spain

  • Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Granisetron
    • Semaglutide
    Estonia

  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Bulgaria Croatia Germany Hungary Poland Portugal +1
1 2 3 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!